Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term macrolide therapy in chronic obstructive pulmonary disease.

× No keyword cloud information.

34 in total

1. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.

Authors: S Kudoh; A Azuma; M Yamamoto; T Izumi; M Ando
Journal: Am J Respir Crit Care Med Date: 1998-06 Impact factor: 21.405

2. Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids.

Authors: J L Urbain; G Vantrappen; J Janssens; E Van Cutsem; T Peeters; M De Roo
Journal: J Nucl Med Date: 1990-09 Impact factor: 10.057

3. Erythromycin and common cold in COPD.

Authors: T Suzuki; M Yanai; M Yamaya; T Satoh-Nakagawa; K Sekizawa; S Ishida; H Sasaki
Journal: Chest Date: 2001-09 Impact factor: 9.410

4. Macrolide resistance among invasive Streptococcus pneumoniae isolates.

Authors: T B Hyde; K Gay; D S Stephens; D J Vugia; M Pass; S Johnson; N L Barrett; W Schaffner; P R Cieslak; P S Maupin; E R Zell; J H Jorgensen; R R Facklam; C G Whitney
Journal: JAMA Date: 2001-10-17 Impact factor: 56.272

5. Ototoxicity with azithromycin.

Authors: M R Wallace; L K Miller; M T Nguyen; A R Shields
Journal: Lancet Date: 1994-01-22 Impact factor: 79.321

6. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Authors: J Wolter; S Seeney; S Bell; S Bowler; P Masel; J McCormack
Journal: Thorax Date: 2002-03 Impact factor: 9.139

Review 7. Prophylactic antibiotic therapy for chronic bronchitis.

Authors: T Staykova; P N Black; E E Chacko; P Poole
Journal: Cochrane Database Syst Rev Date: 2003

8. Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.

Authors: D M Johnson; H S Sader; T R Fritsche; D J Biedenbach; Ronald N Jones
Journal: Diagn Microbiol Infect Dis Date: 2003-09 Impact factor: 2.803

9. The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.

Authors: Dev Banerjee; David Honeybourne; Omer A Khair
Journal: Treat Respir Med Date: 2004

Review 10. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.

Authors: Daniel J Wozniak; Rebecca Keyser
Journal: Chest Date: 2004-02 Impact factor: 9.410

4 in total

1. The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors: Mineki Saito; Hiroe Sejima; Tadasuke Naito; Hiroshi Ushirogawa; Toshio Matsuzaki; Eiji Matsuura; Yuetsu Tanaka; Tatsufumi Nakamura; Hiroshi Takashima
Journal: Virol J Date: 2017-12-04 Impact factor: 4.099

Long-term macrolide therapy in chronic obstructive pulmonary disease.